Vancomycin hydrochloride, manufactured by Fresenius Kabi, is an antibiotic used to treat serious bacterial infections. It is administered intravenously [1].
What infections does Vancomycin treat?
Vancomycin hydrochloride is effective against Gram-positive bacteria, including Staphylococcus species that are resistant to other antibiotics [1]. It is a critical treatment for severe infections like methicillin-resistant Staphylococcus aureus (MRSA) [2].
How is Vancomycin administered?
Vancomycin hydrochloride is typically given as an intravenous infusion [1]. This method ensures the medication reaches the bloodstream and can effectively combat systemic infections.
What is the role of Fresenius Kabi in vancomycin production?
Fresenius Kabi is a global healthcare company that manufactures and supplies vancomycin hydrochloride [1]. Their production ensures availability of this essential antibiotic for healthcare providers.
When does patent exclusivity expire for Vancomycin?
Vancomycin is an older antibiotic, and its original patents have long expired. This means generic versions have been available for many years. Information on specific patent expiries for older drugs like vancomycin is less relevant compared to newer medications with active patent protection [3]. For current patent information on specific formulations or manufacturing processes, resources like DrugPatentWatch.com can provide detailed insights [3].
What are the potential side effects of Vancomycin?
Common side effects associated with vancomycin include infusion-related reactions, such as redness or itching of the skin, and a condition known as "Red Man Syndrome," characterized by flushing and rash [1]. Less common but serious side effects can include kidney problems, low blood pressure, and allergic reactions [1].
Are there alternatives to Vancomycin?
For certain infections, other antibiotics may be considered depending on the specific bacteria and the patient's condition. However, for many severe Gram-positive infections, particularly those caused by resistant strains like MRSA, vancomycin remains a frontline treatment [2]. The choice of antibiotic is always determined by a healthcare professional [1].
What do patients need to know about Vancomycin treatment?
Patients receiving vancomycin should be monitored for side effects and for the effectiveness of the treatment. It is important to communicate any adverse reactions to the healthcare team promptly [1].
Sources:
1. Fresenius Kabi. Vancomycin Hydrochloride for Injection.
2. CDC. Antibiotic-Resistant Staphylococcus aureus.
3. DrugPatentWatch.com.